Dr A.H. Heineken Prize for Medicine 2020 awarded to Karl Deisseroth

3 June 2020

The Royal Netherlands Academy of Arts and Sciences has awarded the 2020 Dr A.H. Heineken Prize for Medicine to Karl Deisseroth, Professor of Bioengineering and of Psychiatry and Behavioural Sciences at Stanford University in California, and Investigator of the Howard Hughes Medical Institute in Maryland, USA.

Deisseroth is receiving the prize for developing optogenetics – a method to influence the activity of nerve cells with light – as well as for developing hydrogel-tissue chemistry, which enables researchers to make biological tissue accessible to light and molecular probes. Both discoveries play an important role in current brain research.

The Heineken Prizes are the Netherlands’ most prestigious international science prizes. Every two years the prizes are awarded to five leading researchers. They were instituted in 1964 by Alfred H. Heineken in honour of his father Dr Henry P. Heineken. The 2020 laureates will be announced in the first week of June.

Deisseroth took brain research a decisive step further

Deisseroth discovered that it is possible to use light of a certain wavelength to switch on a certain group of nerve cells, and if desired at the same time switch off another group with light of a different wavelength. This capability enables spectacular effects, such as influencing an individual subject’s perceptions and movements, and even higher brain functions. One can, for example, alter learning and memory, or change the motivation of an individual for specific actions. Already used around the world for scientific discoveries, optogenetics marks the onset of a true revolution in both basic science and neuropsychiatry, leading to mechanistic research and understanding of crippling conditions such as blindness, Parkinson’s disease, epilepsy, addiction, and depression.

The light-sensitive and transparent brain

Deisseroth first published on his optogenetics discovery in 2005. It had been known for many decades that some microorganisms have light-sensitive ion conduction (through pumps and channels). For example, certain algae are dependent on light to guide movement; when light shines on them, ion channels open and positively-charged ions flow into the cell, causing the single-celled alga to swim towards the light. In July 2004, Deisseroth succeeded in implanting the DNA that encodes these channels into rodent nerve cells and causing light-sensitivity, and over the next decade he developed ways to target specific nerve cell types— and even single cells— in living mice. As a result the targeted cells in the brains of mice could be stimulated with light to control behavior, far more precisely than with medication or electrical stimulation which affect multiple groups of brain cells.

In 2013, Deisseroth and his colleagues introduced another important technology, hydrogel-tissue chemistry. The initial form, called CLARITY, is a way of making brain tissue transparent and accessible to molecular labels, thus allowing researchers to see more clearly how the brain is constructed. Conventional microscopy techniques show nerve cells in detail, but these are two-dimensional images of wafer-thin slices. Some scanning technology, such as MRI and CT, displays three-dimensional images, but shows no details of cells. Achieving transparency through creation of a hydrogel-tissue hybrid, researchers can search through intact brain tissue and investigate which cells are connected and what kind of information they transmit; hydrogel-tissue chemistry variants have also allowed visualizing proteins anchored deep within tissue, reversibly changing tissue dimensions, and labeling and sequencing of RNA molecules in cells within native environments. Widely used for scientific discovery, these methods have also been applied by Deisseroth and colleagues to human tissue, including in patients with autism, epilepsy, and Alzheimer’s disease.

About the laureate

Karl Alexander Deisseroth was born in Boston (Massachusetts) in 1971 and studied biochemistry at Harvard University. He works one day a week in the clinic as a psychiatrist, spending the rest of his time on fundamental neuroscience research. Deisseroth has a tremendous record of achievements, as appears from his many discoveries and publications. In 2010 the journal Nature Methods proclaimed optogenetics to be its 'Method of the Year'. Over the past ten years, Deisseroth has received more than 80 patents for his development of optogenetics and related technologies.

Deisseroth has won dozens of fundamental science prizes, including the McKnight Foundation Scholar Award, the National Academy of Sciences Lounsbery Award, the Breakthrough Prize, the Else Kröner Fresenius Prize for Medical Research, and the Kyoto Prize. Last year the journal Nature Biotechnology declared him the Number 1 'translational researcher across all fields'. He is an elected member of all three US National Academies (Sciences, Medicine, and Engineering).


About the Heineken Prizes

Over the past five decades, the Heineken Prizes have become an internationally renowned distinction. They are the Netherlands’ most prestigious prizes in the arts and sciences. Every two years, five internationally renowned researchers and one artist, who lives and works in the Netherlands, are honoured. The work of the laureates offers new perspectives, achieves unexpected breakthroughs, and opens up new avenues for others. Since 2010 future generations are also celebrated. Four highly promising young researchers working at Dutch research institutes receive the Heineken Young Scientists Awards.

The laureates are selected by juries made up of members of the Royal Netherlands Academy of Arts and Sciences, the Young Academy, and international experts. The Heineken science prizes include a monetary reward of USD 200,000. The artist receives EUR 100,000, half of which is intended for a publication and/or exhibition. The incentive prizes for young scientists are EUR 10,000 each.

The Heineken Prizes were instituted in 1964 by Alfred H. Heineken (1923–2002) in honour of his father Dr Henry P. Heineken (1886–1971). In that year the Dr H.P. Heineken Prize for Biochemistry and Biophysics was awarded for the first time. It has since been joined by five other Heineken Prizes: the Dr A.H. Heineken Prize for Art (1988), for Medicine (1989), for Environmental Sciences (1990) and for History (1990), and the C.L. Carvalho-Heineken Prize for Cognitive Science (2006).

Alfred Heineken’s daughter, Charlene L. de Carvalho-Heineken (b. 1954), is continuing this tradition as chair of the Alfred Heineken Fondsen Foundation and the Dr A.H. Heineken Foundation for Art, which finance the prizes.

More information

For more information, go to www.heinekenprizes.org